TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.56B
AUM Growth
-$71.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
186
New
Increased
Reduced
Closed

Top Buys

1 +$20.3M
2 +$13.5M
3 +$13.2M
4
PODD icon
Insulet
PODD
+$12.6M
5
THC icon
Tenet Healthcare
THC
+$12.1M

Top Sells

1 +$35.4M
2 +$24.2M
3 +$21.6M
4
BMY icon
Bristol-Myers Squibb
BMY
+$13.1M
5
UNH icon
UnitedHealth
UNH
+$13.1M

Sector Composition

1 Healthcare 96.11%
2 Real Estate 2.09%
3 Industrials 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
1
Amgen
AMGN
$161B
$137M 5.36%
616,539
+60,600
JNJ icon
2
Johnson & Johnson
JNJ
$465B
$119M 4.68%
721,779
GILD icon
3
Gilead Sciences
GILD
$152B
$118M 4.63%
1,533,884
-26,000
REGN icon
4
Regeneron Pharmaceuticals
REGN
$61.3B
$116M 4.54%
161,418
+18,365
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$107B
$112M 4.38%
318,043
-12,300
LLY icon
6
Eli Lilly
LLY
$720B
$100M 3.92%
213,352
-75,565
UNH icon
7
UnitedHealth
UNH
$323B
$99.5M 3.89%
206,961
-27,212
MRK icon
8
Merck
MRK
$212B
$84M 3.29%
728,154
+176,032
ABBV icon
9
AbbVie
ABBV
$406B
$73.5M 2.88%
545,629
+34,030
BIIB icon
10
Biogen
BIIB
$21B
$70.6M 2.76%
247,943
+7,017
AZN icon
11
AstraZeneca
AZN
$263B
$69.9M 2.74%
976,676
-15,988
ILMN icon
12
Illumina
ILMN
$14.7B
$63.2M 2.47%
346,414
-11,411
ABT icon
13
Abbott
ABT
$224B
$60.2M 2.36%
552,455
-71,400
PFE icon
14
Pfizer
PFE
$139B
$59.6M 2.33%
1,624,476
-150,600
TMO icon
15
Thermo Fisher Scientific
TMO
$204B
$51.6M 2.02%
98,987
+5,282
ELV icon
16
Elevance Health
ELV
$78.5B
$50.7M 1.98%
114,070
MRNA icon
17
Moderna
MRNA
$10.2B
$41.8M 1.63%
343,695
+21,478
BSX icon
18
Boston Scientific
BSX
$147B
$35.6M 1.39%
657,790
+91,800
DHR icon
19
Danaher
DHR
$150B
$34.3M 1.34%
161,093
+41,875
MDT icon
20
Medtronic
MDT
$123B
$30.3M 1.19%
344,417
-100
IDXX icon
21
Idexx Laboratories
IDXX
$50.8B
$29.4M 1.15%
58,595
DXCM icon
22
DexCom
DXCM
$26.1B
$29.4M 1.15%
228,747
BMY icon
23
Bristol-Myers Squibb
BMY
$88.8B
$29.3M 1.15%
458,498
-205,298
ISRG icon
24
Intuitive Surgical
ISRG
$160B
$28.7M 1.12%
83,980
-28,700
ALNY icon
25
Alnylam Pharmaceuticals
ALNY
$63.1B
$27.2M 1.06%
143,214